IDEAS home Printed from https://ideas.repec.org/p/kob/dpaper/86.html
   My bibliography  Save this paper

Foreign Direct Investment, Technological Capabilities and Performance in the Chinese Pharmaceutical Industry

Author

Listed:
  • Steven White

    (Research Institute for Economics & Business Administration (RIEB), Kobe University, Japan)

  • Hideki Yoshihara

    (Research Institute for Economics & Business Administration (RIEB), Kobe University, Japan)

  • Xielin Liu

    (National Research Center and Technology for Development State Science and Technology Commission of China, China)

Abstract

Does a firm engage in a joint venture with a technologically advanced foreign partner to complement or substitute investments in its own technological capabilities? We address this question in a comparative study of 222 Chinese pharmaceutical manufacturers and Sino-foreign joint ventures. A combination of ANOVA and OLS regression results provide evidence that firms with joint ventures invest more in organizational resources associated with technological capabilities, are higher performing by a number of absolute and relative measures, and have different correlates of high performance than firms without joint ventures. While the study cannot address the question of direction of causality, it does provide support for the view that joint ventures and investments in organizational resources are complementary, or at least correlated, rather than substitution strategies.

Suggested Citation

  • Steven White & Hideki Yoshihara & Xielin Liu, 1997. "Foreign Direct Investment, Technological Capabilities and Performance in the Chinese Pharmaceutical Industry," Discussion Paper Series 86, Research Institute for Economics & Business Administration, Kobe University.
  • Handle: RePEc:kob:dpaper:86
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    More about this item

    Keywords

    Pharmaceutical industry; Technology; China; Foreign investments;
    All these keywords.

    JEL classification:

    • L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
    • O32 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Management of Technological Innovation and R&D
    • O31 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Innovation and Invention: Processes and Incentives
    • F21 - International Economics - - International Factor Movements and International Business - - - International Investment; Long-Term Capital Movements

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:kob:dpaper:86. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Office of Promoting Research Collaboration, Research Institute for Economics & Business Administration, Kobe University (email available below). General contact details of provider: https://edirc.repec.org/data/rikobjp.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.